$ Value
$0
Shares
18,150
Price
$0
Filed
Jan 5
Insider
Name
Loerop James
Title
Chief Business Officer
CIK
0001781549
Roles
Transaction Details
Transaction Date
2026-01-02
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
18,700
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. | The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4. | 50% of the shares underlying these restricted stock units vested on each of December 31, 2024 and December 31, 2025. | The shares underlying these restricted stock units vest as to 33% on January 2, 2025, 33% on January 2, 2026, and 34% on January 2, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Filing Info
Loerop James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | ACRS | M | — |
| 2026-02-03 | ACRS | F | $21K |
| 2026-02-03 | ACRS | M | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-02-01 | ACRS | M | — |
| 2026-02-01 | ACRS | M | — |
| 2026-02-01 | ACRS | M | — |
| 2026-02-01 | ACRS | F | $38K |
| 2026-02-01 | ACRS | M | $0 |
Other Insiders at ACRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Walker Neal
CEO
|
— | — | 2026-02-03 |
|
Loerop James
Chief Business Officer
|
— | — | 2026-02-03 |
|
Balthaser Kevin
Chief Financial Officer
|
— | — | 2026-02-03 |
|
Davis Hugh M.
President and COO
|
— | — | 2026-02-03 |
|
Hall Jesse Wayne
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Kolbeck Roland Wilhelm
Chief Scientific Officer
|
— | — | 2026-02-02 |